TickerStat.com

Satellos Bioscience Inc. (MSLE)

Price—Loading quote

Financial charts

Revenue

No reported data

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

2 annual periodsNewest to oldest
20252024
Research & development$18.4M$14.4M
Operating income−$26.5M−$20.4M
Net income−$24.9M−$20.6M
Basic EPSper diluted share-$1.70-$2.16
Diluted EPSper diluted share-$1.70-$2.16
Review source filings at SEC.gov ↗

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.
Review ownership filings at SEC.gov ↗